Both in Biotechnology
Amgen vs Biogen
Over the past year AMGN returned +52.6% and BIIB returned +65.1%; their daily moves had a correlation of 0.50.
AMGN +52.6% BIIB +65.1%Growth of $1, one year, split-adjusted
| Metric | AMGN | BIIB |
|---|---|---|
| Price | $418.13 | $228.69 |
| Market cap | $226.05B | $33.79B |
| Today | +0.85% | +0.48% |
| 1 month | −4.3% | +3.2% |
| 6 months | +19.9% | +24.4% |
| Year to date | +27.7% | +29.9% |
| 1 year | +54.2% | +68.6% |
| Revenue growth (YoY) | +9.5% | +3.4% |
| Gross margin | 72.0% | 71.6% |
| Net margin | 23.6% | 3.6% |
| P/E (TTM) | 25.9× | 40.5× |
| Price / sales | 5.9× | 3.4× |
| Net cash | -$43.31B | -$6.81B |
| Dividend yield | 2.41% | — |
| Volatility (60d) | 34.0% | 36.0% |
| Short % of float | 2.6% | 3.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).